UB Paderborn / Katalog / Suche / in CDI

Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment

Clinical microbiology and infection, 2019-08, Vol.25 (8), p.951-957

2019

Volltextzugriff (PDF)

Identification and screening of carbapenemase-producing Enterobacteriaceae

Clinical microbiology and infection, 2012-05, Vol.18 (5), p.432-438

2012

Volltextzugriff (PDF)

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

Clinical microbiology and infection, 2012-05, Vol.18 (5), p.413-431

2012

Volltextzugriff (PDF)

KPC-Producing, Multidrug-Resistant Klebsiella pneumoniae Sequence Type 258 as a Typical Opportunistic Pathogen

Antimicrobial Agents and Chemotherapy, 2013-10, Vol.57 (10), p.5144-5146

2013

Volltextzugriff (PDF)

An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10)

Journal of antimicrobial chemotherapy, 2011-07, Vol.66 (7), p.1510-1513

2011

Volltextzugriff (PDF)

Detection in two hospitals of transferable ceftazidime-avibactam resistance in Klebsiella pneumoniae due to a novel VEB β-lactamase variant with a Lys234Arg substitution, Greece, 2019

Euro surveillance : bulletin européen sur les maladies transmissibles, 2020-01, Vol.25 (2)

2020

Volltextzugriff (PDF)

Detection in two hospitals of transferable ceftazidimeavibactam resistance in Klebsiella pneumoniae due to a novel VEB β-lactamase variant with a Lys234Arg substitution, Greece, 2019

Euro surveillance : bulletin européen sur les maladies transmissibles, 2020-01, Vol.25 (2), p.2

2020

Volltextzugriff (PDF)

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues

Clinical microbiology and infection, 2010-02, Vol.16 (2), p.112-122

2010

Volltextzugriff (PDF)

Characterization of pKP1780, a novel IncR plasmid from the emerging Klebsiella pneumoniae ST147, encoding the VIM-1 metallo-β-lactamase

Journal of antimicrobial chemotherapy, 2013-10, Vol.68 (10), p.2259-2262

2013

Volltextzugriff (PDF)

Evolution and Spread of a Multidrug-Resistant Proteus mirabilis Clone with Chromosomal AmpC-Type Cephalosporinases in Europe

Antimicrobial Agents and Chemotherapy, 2011-06, Vol.55 (6), p.2735-2742

2011

Volltextzugriff (PDF)

Characterization of Metallo-β-Lactamase VIM-27, an A57S Mutant of VIM-1 Associated with Klebsiella pneumoniae ST147

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3570-3572

2011

Volltextzugriff (PDF)

VIM-1 Metallo-β-Lactamase-Producing Klebsiella pneumoniae Strains in Greek Hospitals

Journal of Clinical Microbiology, 2003-08, Vol.41 (8), p.3893-3896

2003

Volltextzugriff (PDF)

Characterization of a mobilizable IncQ plasmid encoding cephalosporinase CMY-4 in Escherichia coli

Antimicrobial agents and chemotherapy, 2015-05, Vol.59 (5), p.2964-2966

2015

Volltextzugriff (PDF)

Identification of CMY-2-Type Cephalosporinases in Clinical Isolates of Enterobacteriaceae by MALDI-TOF MS

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2952-2957

2014

Volltextzugriff (PDF)

Characterization of a transmissible plasmid encoding VEB-1 and VIM-1 in Proteus mirabilis

Antimicrobial agents and chemotherapy, 2012-07, Vol.56 (7), p.4024-4025

2012

Volltextzugriff (PDF)

Characterization of a Novel lsa(E)- and lnu(B)-Carrying Structure Located in the Chromosome of a Staphylococcus aureus Sequence Type 398 Strain

Antimicrobial agents and chemotherapy, 2016-02, Vol.60 (2), p.1164-1166

2016

Volltextzugriff (PDF)

Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers

Clinical microbiology and infection, 2013-09, Vol.19 (9), p.E412-E415

2013

Volltextzugriff (PDF)

Characterization of pKP1433, a Novel KPC-2-Encoding Plasmid from Klebsiella pneumoniae Sequence Type 340

Antimicrobial Agents and Chemotherapy, 2013-07, Vol.57 (7), p.3427-3429

2013

Volltextzugriff (PDF)

Increased Hydrolysis of Oximino-β-Lactams by CMY-107, a Tyr199Cys Mutant Form of CMY-2 Produced by Escherichia coli

Antimicrobial agents and chemotherapy, 2015-12, Vol.59 (12), p.7894-7898

2015

Volltextzugriff (PDF)

Sequence of pR3521, an IncB Plasmid from Escherichia coli Encoding ACC-4, SCO-1, and TEM-1 β-Lactamases

Antimicrobial Agents and Chemotherapy, 2011-01, Vol.55 (1), p.376-381

2011

Volltextzugriff (PDF)

GES-13, a β-Lactamase Variant Possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2010-03, Vol.54 (3), p.1331-1333

2010

Volltextzugriff (PDF)

Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations

Journal of antimicrobial chemotherapy, 2014-08, Vol.69 (8), p.2076-2080

2014

Volltextzugriff (PDF)

CMY-31 and CMY-36 Cephalosporinases Encoded by ColE1-Like Plasmids

Antimicrobial Agents and Chemotherapy, 2009-03, Vol.53 (3), p.1256-1259

2009

Volltextzugriff (PDF)

Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella

International Journal of Antimicrobial Agents, 2004-06, Vol.23 (6), p.547-555

2004

Volltextzugriff (PDF)

Does it ever make sense to treat a bacterial infection with a drug against which the responsible pathogen possesses a resistance mechanism?

Clinical microbiology and infection, 2011-08, Vol.17 (8), p.1126-1127

2011

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment

Identification and screening of carbapenemase-producing Enterobacteriaceae

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

KPC-Producing, Multidrug-Resistant Klebsiella pneumoniae Sequence Type 258 as a Typical Opportunistic Pathogen

An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10)

Detection in two hospitals of transferable ceftazidime-avibactam resistance in Klebsiella pneumoniae due to a novel VEB β-lactamase variant with a Lys234Arg substitution, Greece, 2019

Detection in two hospitals of transferable ceftazidimeavibactam resistance in Klebsiella pneumoniae due to a novel VEB β-lactamase variant with a Lys234Arg substitution, Greece, 2019

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues

Characterization of pKP1780, a novel IncR plasmid from the emerging Klebsiella pneumoniae ST147, encoding the VIM-1 metallo-β-lactamase

Evolution and Spread of a Multidrug-Resistant Proteus mirabilis Clone with Chromosomal AmpC-Type Cephalosporinases in Europe

Characterization of Metallo-β-Lactamase VIM-27, an A57S Mutant of VIM-1 Associated with Klebsiella pneumoniae ST147

VIM-1 Metallo-β-Lactamase-Producing Klebsiella pneumoniae Strains in Greek Hospitals

Characterization of a mobilizable IncQ plasmid encoding cephalosporinase CMY-4 in Escherichia coli

Identification of CMY-2-Type Cephalosporinases in Clinical Isolates of Enterobacteriaceae by MALDI-TOF MS

Characterization of a transmissible plasmid encoding VEB-1 and VIM-1 in Proteus mirabilis

Characterization of a Novel lsa(E)- and lnu(B)-Carrying Structure Located in the Chromosome of a Staphylococcus aureus Sequence Type 398 Strain

Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers

Characterization of pKP1433, a Novel KPC-2-Encoding Plasmid from Klebsiella pneumoniae Sequence Type 340

Increased Hydrolysis of Oximino-β-Lactams by CMY-107, a Tyr199Cys Mutant Form of CMY-2 Produced by Escherichia coli

Sequence of pR3521, an IncB Plasmid from Escherichia coli Encoding ACC-4, SCO-1, and TEM-1 β-Lactamases

GES-13, a β-Lactamase Variant Possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa

Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations

CMY-31 and CMY-36 Cephalosporinases Encoded by ColE1-Like Plasmids

Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella

Does it ever make sense to treat a bacterial infection with a drug against which the responsible pathogen possesses a resistance mechanism?

Suchergebnisse filtern